课题基金 / 基金详情

Study on the possibility for drug utilization of peptidergic neurotransmitter using knockout mouse

Study on the possibility for drug utilization of peptidergic neurotransmitter using knockout mouse
利用基因敲除小鼠研究肽能神经递质药物利用的可能性
批准号:
07557157
负责人:
BABA Akemichi
金额:
$10.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

BABA Akemichi的其他基金

相似基金

相关文献

中文摘要
翻译
PACAP与血管活性肠多肽(vasoactive intestinal polypeptide, VIP)的氨基酸序列同源性高达68%,可调节中枢和外周神经系统的多种生理功能。目前已克隆出3个编码PACAP/VIP受体亚型的基因,它们与PACAP具有较高的亲和力,但每种亚型的生理意义尚未完全表征。为了阐明PACAP信号系统的作用,我们在胚胎干细胞中使用基因靶向来破坏PACAP受体基因的外显子2,并对突变小鼠和野生型小鼠进行了表征。突变小鼠脑内PACAP-27结合和cAMP生成减少[^<125>]。然而,这些突变的老鼠是可以存活和繁殖的,并且在形态上、组织学上和电生理学上与它们的野生型同类没有区别。在野生型小鼠和大鼠交感神经系统中均可见到PACAP受体和PACAP的共表达。在交感神经元中,PACAP在转录水平上刺激PACAP受体和PACAP mrna的表达。研究了小鼠胰岛素瘤细胞产生PACAP的机制。综上所述,这些结果表明,PACAP作为自分泌或旁分泌调节因子,有助于交感肾上腺系统的持续激活,并且PACAP通过自分泌机制调节葡萄糖刺激的β细胞胰岛素分泌。然而,完整的PACAP受体并不是正常小鼠发育或生存的先决条件。
英文摘要
PACAP has an amino acid sequence identity of 68% with vasoactive intestinal polypeptide (VIP) and regulates a wide range of physiological functions in the central and peripheral nervous systems. Three genes encoding PACAP/VIP receptor subtypes, which bind PACAP with a high affinity, have been cloned, but the physiological significance of each subtype has not been completely characterized. To elucidate the role of the PACAP signaling system, we have used gene targeting in embryonic stem cells to disrupt exon 2 of the PACAP receptor gene, and characterized the mutant mice as well as wildtype mice.1. The mutant mice had reduced [^<125>I]PACAP-27 binding and cAMP production in their brains.2. The mutant mice, however, were viable and fertile, and morphologically, histologically and electrophysiologically indistinguishable from their wild-type counterparts.3. Coexpression of PACAP receptor and PACAP was seen in the sympathetic nervous system of the wild-type mice and rats.4. In the sympathetic neurons, PACAP stimulates the expression of PACAP receptor and PACAP mRNAs at a transcriptional level.5. The mechanism of the PACAP production was studied in mouse insulinoma cells.In conclusion, these results suggest that PACAP acts as a autocrine or paracrine regulatory factor and contributes to sustained activation of the sympathoadrenal system, and that PACAP regulates glucose-stimulated insulin secretion from beta cells by an autocrine mechanism. However, the intact PACAP receptor is not a prerequisite for normal mouse development of for survival.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Hiroyuki Nogi: "Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor mRNA in the rat adrenal gland : localization by in situ hybridization and identification of splice variants" Jpn.J.Pharmacol.75. 203-207 (1997)
Hiroyuki Nogi:“大鼠肾上腺中的垂体腺苷酸环化酶激活多肽(PACAP)受体 mRNA:通过原位杂交定位和剪接变体的鉴定”Jpn.J.Pharmacol.75。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hitoshi Hashimoto: "Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Receptor : Structure and Functional Characterization" Vitamins (Japan). 71. 285-296 (1997)
Hitoshi Hashimoto:“垂体腺苷酸环化酶激活多肽(PACAP)受体:结构和功能表征”维生素(日本)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroyuki Nogi: "Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP),PACAP receptor,vasoactive intestinal polypeptide (VIP),and VIP receptors in the rat superior cervical ganglion" Neurosci.Lett.227. 37-40 (1997)
Hiroyuki Nogi:“垂体腺苷酸环化酶激活多肽 (PACAP)、PACAP 受体、血管活性肠多肽 (VIP) 和 VIP 受体在大鼠颈上神经节中的 mRNA 分布”Neurosci.Lett.227。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 12 条
    Functional analyses of novel mitochondrial fusion inhibitor HPGBin the regulation of heart and metabolism
    • 批准号:
      23659143
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      BABA Akemichi
    • 依托单位:
    Molecular basis study on PACAP gene as a risk factor for schizophrenia
    • 批准号:
      21390069
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2009
    • 负责人:
      BABA Akemichi
    • 依托单位:
    Molecular basis on function and clinical implication of neuropeptide PACAP
    • 批准号:
      18209009
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.28万
    • 财政年份:
      2006
    • 负责人:
      BABA Akemichi
    • 依托单位:
    Molecular pharmacological aspects of the neuropeptide PACAP in brain and pancreas
    • 批准号:
      15209009
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.7万
    • 财政年份:
      2003
    • 负责人:
      BABA Akemichi
    • 依托单位:
    国内基金
    海外基金
    基于四面体框架核酸的PACAP透屏障递送系统构建及其治疗糖尿病视网膜病变的机制研究
    海马DG-PACAP能神经元调控KEAP1与CaMKII双信号干扰颗粒细胞功能研究MDD-SI苔藓纤维通路传导障碍机制及复方柴金解郁方干预作用
    • 批准号:
      82560922
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33.00万元
    • 批准年份:
      2025
    • 负责人:
      李姿蓉
    • 依托单位:
    基于神经生长因子介导背根神经节TRPV1-PACAP信号通路活化探讨电针改善糖尿病膀胱重塑的作用机制研究
    • 批准号:
      82405178
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2024
    • 负责人:
      韩栩珂
    • 依托单位:
    PACAP38 通过 AMPK 和 p62 激活 NRF2 抑制铁死亡减轻放射性心肌损伤的研究